# Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants

> **NCT01106469** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 74 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-41443532
- **DRUG:** JNJ-41443532
- **DRUG:** JNJ-41443532
- **DRUG:** JNJ-41443532
- **DRUG:** JNJ-41443532
- **DRUG:** Placebo
- **DRUG:** JNJ-41443532

## Key facts

- **NCT ID:** NCT01106469
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** —
- **Final completion:** 2010-07
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2014-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106469, "Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of Single and Multiple Ascending Doses of JNJ-41443532 in Healthy Male Participants". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01106469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*